SAFETY EVALUATION OF OLOPATADINE HCL OPHTHALMIC SOLUTION 0.77%, A TOPICAL OCULAR ANTI-ALLERGIC AGENT, IN ASYMPTOMATIC SUBJECTS.

被引：0
|
作者：
Meier, E. J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2014年 / 113卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P293
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 9 条
  • [1] SAFETY EVALUATION OF OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.77% IN PEDIATRIC SUBJECTS WITH ASYMPTOMATIC EYES
    Meier, Edward John
    Narvekar, Abhijit
    Bae, Kyong
    Sall, Kenneth N.
    Wirta, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [2] The in vitro and in vivo ocular pharmacology of Olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent
    Yanni, JM
    Stephens, DJ
    Miller, ST
    Weimer, LK
    Graff, G
    Parnell, D
    Lang, LS
    Spellman, JM
    Brady, MT
    Gamache, DA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4724 - 4724
  • [3] The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent
    Yanni, JM
    Stephens, DJ
    Miller, ST
    Weimer, LK
    Graff, G
    Parnell, D
    Lang, LS
    Spellman, JM
    Brady, MT
    Gamache, DA
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1996, 12 (04) : 389 - 400
  • [4] OCULAR TOLERABILITY AND SAFETY ASSESSMENT OF DA-6034 OPHTHALMIC SOLUTION IN HEALTHY SUBJECTS.
    Yoon, S.
    Gu, N.
    Kim, S.
    Lim, K. S.
    Yu, K. S.
    Jang, I. J.
    Shin, S. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S56 - S56
  • [5] Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye
    Mah, F. S.
    O'Brien, T.
    Kim, T.
    Torkildsen, G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 441 - 447
  • [6] Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model
    McLaurin, Eugene
    Narvekar, Abhijit
    Gomes, Paul
    Adewale, Adeniyi
    Torkildsen, Gail
    CORNEA, 2015, 34 (10) : 1245 - 1251
  • [7] Ocular safety of INS365 ophthalmic solution, a P2Y2 agonist, in healthy subjects.
    Mundasad, MV
    Yerxa, BR
    Allgood, VE
    Evans, RM
    Gorden, JC
    Novack, GD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S928 - S928
  • [8] A Comparison of the Onset of Action and Duration of Action of Olopatadine Hydrochloride Ophthalmic Solution 0.7% to Loratadine 10 mg in Preventing Ocular Itching in Subjects with Allergic Conjunctivitis
    Chin, Jason
    Quealy, Kara
    Gomes, Paul
    Greiner, Jack
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB106 - AB106
  • [9] Evaluation of the high affinity IgE receptor alpha-IgG1 Fc fusion protein (FCER1A-Fc) as a topical ocular anti-allergic agent
    Homma, Toshiki
    Yokoyama, Kazumasa
    Itoh, Fumiaki
    Sakamoto, Takashi
    Yamagishi, Mika
    Ra, Chisei
    Suzuki, Yasuhiko
    Inada, Yoichi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB162 - AB162
1